Structure Therapeutics is trading 4.27% higher at $24.93 after hours, with no clear catalyst identified.
- The regular-session close fell 6.38% to $23.91 on October 12, extending a weakening run.
- Its investor-relations page lists September 8 as the latest release, with no October 12 announcement shown; available evidence does not establish a company-specific reason.